Thermo Fisher Scientific Inc Common Stock · Transaction Jul 10, 2026 · Filed Jul 17, 2026 · $1,001 to $15,000
NEW YORK STOCK EXCHANGE, INC. · TMO
+1.53% · +$10.16 · Vol Not reported
Market closed · last close 4:00 PM ET · price as of 16:00:00 ET
Thermo Fisher Scientific Inc
Life Sciences Tools & Services
$673.20
Follow $TMO
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $TMO by emailVeridion Score
BETAHIGH CONF · 6 of 6 factors measuredWed Oct 14 · last completed session · Pre-market · regular session opens 9:30 ET · TMO
MethodologyTMO
Thermo Fisher Scientific Inc
Wed Oct 14 · last completed session · Pre-market · regular session opens 9:30 ET
Highest qualified
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
75/ 100
Veridion Score
Highest qualified · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Confidence: HIGH · 6 of 6 factors measured · Wed Oct 14 · last completed session · Pre-market · regular session opens 9:30 ET
AI Analysis
SovereignWhy is TMO moving today?
Sovereign unlock connects news, insider activity, analyst moves, and available price action.
About Thermo Fisher Scientific Inc
MEASURING & CONTROLLING DEVICES, NECListed since
1972
Employees
125K
Country
US
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$664.01
Day high
$681.50
Day low
$659.00
Previous close
$663.04
52W high
$681.50
-1.22% from high
52W low
$438.34
97% of range
Market cap
$248.9B
P/E
35.60×
EPS
$18.57
Beta
-0.17
Shares out
369.7M
Avg volume
2.2M
VWAP
$663.04
Last session
Price history computed in-house
1W
+3.25%
1M
+4.96%
3M
+26.43%
1Y
+27.53%
YTD
+16.18%
SMA 50 $632.12 · above
SMA 200 $546.24 · above
52W position 97%
TMO overview
Veridion Score
75
Registered · 2026-10-14
6 of 6 factors measured
Latest receipt rows
5
Dan Newhouse · Sale
13F holders
2
Farallon Capital Management LLC
Receipt-backed holder profiles
Related filings and maps
Public disclosures
Congress activity in TMO
43 filers · 68 buys · 71 sells (1 labeled S (partial)) · Aug 19, 2014 to Jul 10, 2026 · House 120 / Senate 19
All available history · Latest 5 of 139 lines · Read Oct 15, 2026, 1:24 PM UTC
Official filing ↗
Dwight EvansSell
Thermo Fisher Scientific Inc Common Stock · Transaction May 7, 2026 · Filed May 15, 2026 · $1,001 to $15,000
Thermo Fisher Scientific Inc Common Stock · Transaction Oct 31, 2025 · Filed Nov 21, 2025 · $1,001 to $15,000
Thermo Fisher Scientific Inc Common Stock · Transaction Oct 30, 2025 · Filed Nov 21, 2025 · $1,001 to $15,000
Thermo Fisher Scientific Inc Common Stock · Transaction Oct 30, 2025 · Filed Nov 21, 2025 · $1,001 to $15,000
Federal contracts
TMO contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for TMO in this window.
Lobbying spend
TMO lobbying filings, year to date.
Registered lobbying filings matched to Thermo Fisher Scientific Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for TMO in this window.
Analyst ratings
Sovereign unlock shows available analyst consensus for TMO.